Tue. 9 Apr 2024, 9:18am ET
Benzinga
News
According to its most recent 10-K filing as of December 31, 2023, Synaptogenix reported a cash balance of $28.7 million. Additionally, following a recent reverse split, the Company now has approximately 1,085,333 outstanding shares.